Nutrition, Insulin, Insulin-like Growth Factors and Cancer

Hormone and Metabolic Research

Volumn 35, Issue 11-12, 2003, Pages 694-704

  Giovannucci, E ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acromegaly; Diabetes; Dietary fat; Epidemiology; Exercise; Obesity; Protein

Indexed keywords

INSULIN; SOMATOMEDIN;

ACROMEGALY; CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; DIETARY INTAKE; HUMAN; HYPERINSULINEMIA; HYPOINSULINEMIA; LIFESTYLE; NUTRITION; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ACROMEGALY; ANIMALS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MODELS, BIOLOGICAL; NEOPLASMS; NUTRITION PHYSIOLOGY; RISK FACTORS;

EID: 0346725867     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814147     Document Type: Review

References (153)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-1308
2. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-179
3. Gerber M, Corpet D. Energy balance and cancers. Eur J Cancer Prev 1999; 8: 77-89
4. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3: 687-695
5. Kaaks R. Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer Causes Control 1996; 7: 605-625
6. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S
7. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003; 54: 131-152
8. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000; 36: 1224-1228
9. Bruce WR, Wolever TM, Giacca A. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 2000; 37: 19-26
10. Jones J, Clemmons D. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34
11. Hall K, Hilding A, Thoren M. Determinants of circulating insulin-like growth factor-1. J Endocrinol Invest 1999; 22: 48-57
12. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994; 42: 145-151
13. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995; 80: 443-449
14. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-878
15. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995; 80: 2282-2288
16. Ooi GT, Tseng LY, Tran MQ, Rechler MM. Insulin rapidly decreases insulin-like growth factor binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol 1992; 6: 2219-2228
17. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PD. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18 868-18 876
18. Katz LEL, Cohen P, Rosenfeld R. Clinical significance of IGF binding proteins. Endocrinologist 1995; 5: 36-43
19. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinologica 1991; 124 Suppl 2: 74-85
20. Lee PD, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 1993; 204: 4-29
21. Cotterill AM, Holly JM, Wass JA. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clin Endocrinol 1993; 39: 357-362
22. Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988; 67: 1225-1230
23. Suikkari AM, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J Clin Endocrinol Metab 1989; 68: 141-144
24. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991; 73: 964-968
25. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11: 599-602
26. Suikkari AM, Koivisto VA, Rutamen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266-272
27. Argente J, Caballo N, Barrios V, Munoz MT, Pozo J, Chowen JA et al. Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. Horm Res 1997; 48 (Suppl 4): 16-18
28. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GBJ. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs) and the IGF-binding proteins. J Clin Endocrinol Metab 1992; 75: 762-767
29. Strasser-Vogel B, Blum WF, Past R, Kessler U, Hoeflich A, Meiler B et al. Insulin-like growth factor (IGF)-I and -II and IGF-binding Proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment. J Clin Endocrinol Metab 1995; 80: 1207-1213
30. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1 and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Dis 1997; 21: 355-359
31. Flier JS, Usher P, Moses AC. Monoclonal antibody to the type 1 insulin-like growth factor (IGF-1) receptor blocks IGF-1 receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-1 and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 1986; 83: 664-668
32. Moller DE, Flier JS. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-948
33. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-320
34. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J 1990; 270: 383-390
35. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev 1992; 8: 229-257
36. Gutierrez L, Magee AI, Marshall CJ, Hancock JF. Post-translational processing of p21 ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J 1989; 8: 1093-1098
37. Leitner JW, Kline T, Carel K, Goalstone M, Draznin B. Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology 1997; 138: 2211-2214
38. Goalstone ML, Wall K, Leitner JW, Kurowski T, Ruderman N, Pan SJ et al. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals. Diabetologia 1999; 42: 310-316
39. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 18: 801-831
40. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101
41. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 1247-1250
42. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 1988; 81: 968-975
43. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982; 55: 999-1002
44. Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting. Metabolism 1985; 34: 391-395
45. Devine A, Rosen C, Mohan S, Baylink D, Prince RL. Effects of zinc and other nutritional factors on insulin-like growth factor 1 and insulin-like growth factor binding proteins in postmenopausal women. Am J Clin Nutr 1998; 68: 200-206
46. Estivariz CF, Ziegler TR. Nutrition and the insulin-like growth factor system. Endocrine 1997; 7: 65-71
47. Clausen T, Dorup I. Micronutrients, minerals and growth control. In: Sandstrom B, Walter P (eds). Role of Trace Elements for Health Promotion and Disease Prevention. Basel: Karger, 1998: 84-92
48. MacDonald RS. The role of zinc in growth and cell proliferation. J Nutr 2000; 130: 1500S-1508S
49. Ninh NX, Thissen JP, Collette L, Gerard G, Khoi HH, Ketelslegers JM. Zinc supplementation increases growth and circulating insulin-like growth factor 1 (IGF-1) in growth-retarded Vietnamese children. A J Clin Nutr 1996; 63: 514-519
50. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002; 11: 852-861
51. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB et al. Nutritional predictors of insulin-like growth factor 1 and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003; 12: 84-89
52. Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The association of diet with serum insulin-like growth factor 1 and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 2002; 11: 1441-1448
53. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M et al. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men. Br J Cancer 2003; 88: 1682-1686
54. Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, Yu MC. Determinants of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 2003; 12: 739-746
55. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 1999; 17: 3291-3298
56. Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS et al. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assn 1999; 99: 1228-1233
57. Hong Y, Pedersen NL, Brismar K, Hall K, De Faire U. Quantitative genetic analyses of insulin-like growth factor-1 (IGF-1), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 1996; 81: 1791-1797
58. Kao PC, Matheny AP, Lang CA. Insulin-like growth factor-1 comparisons in healthy twin children. J Clin Endocrinol Metab 1994; 78: 310-312
59. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143
60. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-260
61. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-1007
62. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986; 62: 922-927
63. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-228
64. Koivisto VA, Yki-Jarvinen H, DeFronzo RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1986; 1: 445-481
65. Regensteiner JG, Mayer EJ, Shetterly SM, Eckel RH, Haskell WL, Marshall JA et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care 1991; 14: 1066-1074
66. Dowse GK, Zimmet PZ, Gareeboo H, George K, Alberti MM, Tuomilehto J et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 271-282
67. Lindgarde F, Saltin B. Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged men. Diabetologia 1981; 20: 134-138
68. Wang JT, Ho LT, Tang KT, Wang LM, Chen YD, Reaven GM. Effect of habitual physical activity on age-related glucose intolerance. J Am Geriatr Soc 1989; 37: 203-209
69. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984; 26: 355-360
70. Burstein R, Polychronakos C, Toews CJ, MacDougall JD, Guyda HJ, Posner BI. Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changes. Diabetes 1985; 34: 756-760
71. Blair SN, Kohl HW, Gordon NF, Paffenbarger RS Jr. How much physical activity is good for health? Annu Rev Public Health 1992; 13: 99-126
72. Kriska AM, Bennett PH. An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention. Diabetes Metab Rev 1992; 8: 355-372
73. Ross R. Effects of diet-and exercise-induced weight loss on visceral adipose tissue in men and women. Sports Med 1997; 24: 55-64
74. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 63-67
75. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-368
76. Wolever TMS, Jenkins DJ, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr 1991; 54: 846-854
77. Trout DL, Behall KM, Osilesi O. Prediction of glycemic index for starchy foods. Am J Clin Nutr 1993; 58: 873-878
78. Daly ME, Vale C, Walker M, Alberti K, Mathers JC. Dietary carbohydrates and insulin sensitivity - a review of the evidence and clinical implications. Am J Clin Nutr 1997; 66: 1072-1085
79. Thresher JS, Podolin DA, Wei Y, Mazzeo RS, Pagliassotti MJ. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Phys 2000; 279: R1334-1340
80. Reiser S, Bohn E, Hallfrisch J, Michaelis OE 4th, Keeney M, Prather ES. Serum insulin and glucose in hyperinsulinemic subjects fed three different levels of sucrose. Am J Clin Nutr 1981; 34: 2348-2358
81. Reiser S, Handler HB, Gardner LB, Hallfrisch JG, Michaelis OE, Prather ES. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and gluccose response to a sucrose load. Am J Clin Nutr 1979; 32: 2206-2216
82. Daly ME, Vale C, Walker M, Littlefield A, Alberti KG, Mathers JC. Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr 1998; 67: 1186-1196
83. Hallfrisch J, Ellwood KC, Michaelis OE, Reiser S, O'Dorisio TM, Prather ES. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr 1983; 113: 1819-1826
84. Manolio TA, Savage PJ, Burke GL, Hilner JE, Liu K, Orchard TJ et al. Correlates of fasting insulin levels in young adults: the CARDIA study. J Clin Epidemiol 1991; 44: 571-578
85. Rivellese M, De Natale C, Lilli S. Type of dietary fat and insulin resistance. Ann NY Acad Sci 2002; 967: 329-335
86. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44: 805-817
87. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol 1998; 148: 4-16
88. Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC et al. The association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73: 61-67
89. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. J Clin Invest 1996; 98: 1195-1209
90. Pedersen O. Genetics of insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 113-118
91. Binoux M, Gourmelen M. Statural development parallels IGF I levels in subjects of constitutionally variant stature. Acta Endocrinol 1987; 114: 524-530
92. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K et al. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752
93. Proos LA. Anthropometry in adolescence - secular trends, adoption, ethnic and environemental differences. Horm Res 1993; 39 (Suppl 3): 18-24
94. Hauspie RC, Vercauteren M, Susanne C. Secular changes in growth and maturation: an update. Acta Paediatr Suppl 1997; 423: 20-27
95. Cole TJ. Secular trends in growth. Proc Nutr Soc 2000; 59: 317-324
96. Gunnell D, Okasha M, Davey Smith G, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001; 23: 313-342
97. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 13-21
98. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New Engl J Med 2003; 348: 1625-1638
99. Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. E J Cancer Prev 2002; 11 Suppl 2: S94-S100
100. Nomura AM. Body size and prostate cancer. Epidemiol Rev 2001; 23: 126-131
101. Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 2003; 95: 1240-1244
102. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001; 93: 783-789
103. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991; 40: 101-104
104. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994; 79: 1310-1316
105. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. A prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996; 88: 1118-1126
106. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001; 10: 287-301
107. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses" Health Study Research Group. J Natl Cancer Inst 1997; 89: 948-955
108. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921-929
109. Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Colditz GA. A prospective study of recreational physical activity and breast cancer risk. Arch Intern Med 1999; 159: 2290-2296
110. Giovannucci E, Leitzmann M, Spiegelman D, Rimm EB, Colditz GA, Stampfer MJ et al. A prospective study of physical activity and prostate cancer in male health professionals. Cancer Res 1998; 58: 5117-5122
111. Fung TT, Hu FB, Yu J, Chu NF, Spiegelman D, Tofler GH et al. Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol 2000; 152: 1171-1178
112. Fung T, Hu FB, Fuchs CS, Giovannucci E, Hunter DJ, Stampfer MJ et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 2003; 163: 309-314
113. Giovannucci E, Rimm EB, Liu Y, Willett WC. Height, predictors of C-peptide and cancer risk in men. Int J Epidemiol (in press)
114. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002; 132: 2350S-2355S
115. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS et al. Calcium supplements for the prevention of colorectal adenomas. The Calcium Polyp Prevention Study Group. N Engl J Med 1999; 340: 101-107
116. Layman DK, Shiue H, Sather C, Erickson DJ, Baum J. Increased dietary protein modifies glucose and insulin homeostasis in adult women during weight loss. J Nutr 2003; 133: 405-410
117. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB et al. Prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547
118. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417-422
119. Lindblad P, Chow WH, Chan JM, Bergstrom A, Wolk A, Gridley G et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999; 42: 107-112
120. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD et al. The relation of type 2 diabetes and cancer. Diabetes Technol Ther 2001; 3: 263-274
121. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 1998; 182: 3-11
122. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995; 16: 117-142
123. Sasaoka T, Draznin B, Leitner WJ, Langlois WJ, Olefsky JM. She is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem 1994; 269: 10 734-10 738
124. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092-1100
125. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-1154
126. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H et al. Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600
127. Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO et al. Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 1207-1211
128. Palmqvist R, Stattin P, Rinaldi S, Biessey C, Stenling R, Riboli E et al. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in Northern Sweden. Int J Cancer 2003; 107: 89-93
129. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao T, Hennekens CH et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 1999; 91: 620-625
130. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D et al. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999; 83: 15-17
131. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N et al. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9: 345-349
132. Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST. High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 2001; 88: 107-113
133. Palmqvist R, Hallmans C, Rinaldi S, Biessey C, Stenling R, Riboli E et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002; 50: 642-646
134. Probst-Hensch NM, Yuan JM, Stanczyk FZ, Gao YT, Ross RK, Yu MC. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001; 85: 1695-1699
135. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998; 279: 563-566
136. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced stage prostate cancer. J Natl Cancer Inst 2002; 94: 1099-1106
137. Stattin P, Bylund A, Rinaldi S, Biessey C, Dechaud H, Stenman UH et al. Plasma insulin-like growth factor-1, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000; 92: 1910-1917
138. Shi R, Berkel HJ, Yu H. Insulin-like growth factor-1 and prostate cancer: a meta-analysis. Br J Cancer 2001; 85: 991-996
139. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396
140. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000; 88: 828-832
141. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Insulin-like growth factor 1 (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 1566-1573
142. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S et al. Prospective study of IGF-1, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 2002; 13: 307-316
143. Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR et al. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2002; 11: 705-712
144. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000; 60: 3744-3748
145. Orme SM, McNally RJ, Cartwrigh RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998; 83: 2730-2734
146. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 2002; 13: 395-400
147. Bang P, Ahlsen M, Berg U, Carlsson-Skwirut C. Free insulin-like growth factor 1: are we hunting a ghost? Horm Res 2001; 55 Suppl 2: 84-93
148. Rechler M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - what's IGF got to do with it? Endocrinology 1997; 138: 2645-2647
149. Ferry RJJ, Cerri RW, Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 1999; 51: 53-67
150. Taylor AM, Dunger DB, Preece MA, Holly JM, Smith CP, Wass JA et al. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol 1990; 32: 229-239
151. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH et al. Recombinant human insulin-like growth factor (IGF)-binding protein-I inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994; 135: 1913-1920
152. Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Growth Regul 1996; 6: 158-164
153. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531-1543